Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence

J. D. Pradeep; G. P. R. Clunie; K. Gaffney; N. J. Innes; A. Brooksby; P. Bradley; A. Gulati

doi:10.1093/rheumatology/ken425

Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence

J. D. Pradeep, G. P. R. Clunie, K. Gaffney, N. J. Innes, A. Brooksby, P. Bradley, A. Gulati

Norwich Medical School

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	195
Number of pages	1
Journal	Rheumatology
Volume	48
Issue number	2
DOIs	https://doi.org/10.1093/rheumatology/ken425
Publication status	Published - Feb 2009

Keywords

England
Humans
Immunosuppressive Agents/administration & dosage
Mycobacterium tuberculosis/isolation & purification
Practice Guidelines as Topic
Rheumatology
Tuberculosis/diagnosis
Tumor Necrosis Factor-alpha/antagonists & inhibitors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/rheumatology/ken425

Cite this

Pradeep, J. D., Clunie, G. P. R., Gaffney, K., Innes, N. J., Brooksby, A., Bradley, P., & Gulati, A. (2009). Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence. Rheumatology, 48(2), 195. https://doi.org/10.1093/rheumatology/ken425

@article{09d5ee3685414ef985a3a9697d1c93bb,

title = "Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence",

keywords = "England, Humans, Immunosuppressive Agents/administration & dosage, Mycobacterium tuberculosis/isolation & purification, Practice Guidelines as Topic, Rheumatology, Tuberculosis/diagnosis, Tumor Necrosis Factor-alpha/antagonists & inhibitors",

author = "Pradeep, {J. D.} and Clunie, {G. P. R.} and K. Gaffney and Innes, {N. J.} and A. Brooksby and P. Bradley and A. Gulati",

year = "2009",

month = feb,

doi = "10.1093/rheumatology/ken425",

language = "English",

volume = "48",

pages = "195",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "2",

}

Pradeep, JD, Clunie, GPR, Gaffney, K, Innes, NJ, Brooksby, A, Bradley, P & Gulati, A 2009, 'Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence', Rheumatology, vol. 48, no. 2, pp. 195. https://doi.org/10.1093/rheumatology/ken425

Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence. / Pradeep, J. D.; Clunie, G. P. R.; Gaffney, K.; Innes, N. J.; Brooksby, A.; Bradley, P.; Gulati, A.

In: Rheumatology, Vol. 48, No. 2, 02.2009, p. 195.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence

AU - Pradeep, J. D.

AU - Clunie, G. P. R.

AU - Gaffney, K.

AU - Innes, N. J.

AU - Brooksby, A.

AU - Bradley, P.

AU - Gulati, A.

PY - 2009/2

Y1 - 2009/2

KW - England

KW - Humans

KW - Immunosuppressive Agents/administration & dosage

KW - Mycobacterium tuberculosis/isolation & purification

KW - Practice Guidelines as Topic

KW - Rheumatology

KW - Tuberculosis/diagnosis

KW - Tumor Necrosis Factor-alpha/antagonists & inhibitors

U2 - 10.1093/rheumatology/ken425

DO - 10.1093/rheumatology/ken425

M3 - Letter

C2 - 19033354

VL - 48

SP - 195

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 2

ER -